Latest News and Press Releases

Shares of MoonLake Immunotherapeutics are down over 85% today. Block & Leviton is investigating MoonLake's public statements about its drug trials.

Block & Leviton LLP announces a securities fraud lawsuit has been filed against Quanex Building Products Corp (NX). Investors should contacte the firm.

Investors who have lost money in Replimune (REPL) stock should contact Block & Leviton by September 22 to join the securities fraud lawsuit.

Block & Leviton LLP is investigating Barnes & Noble Education Inc. (BNED) for potential securities fraud. Investors should contact the firm to learn more.

Block & Leviton is investigating aTyr Pharma after the company announced that its Phase 3 trial for efzofitimod failed to meet its primary endpoint.

Block & Leviton announces that a securities fraud lawsuit has been filed against Lantheus Holdings Inc. (Nasdaq: LNTH). Investors should contactthe firm.

Block & Leviton LLP is investigating PetMed Express (NASDAQ: PETS) for securities fraud. Investors who have lost money in PetMeds should contact the firm.

Block & Leviton is investigating BellRing Brands' disclosures. Investors who have lost money in BRBR should contact the firm to potentially recover losses.

Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Replimune Group (Nasdaq: REPL). Investors should contact the firm.

Block & Leviton LLP is investigating Marex Group PLC (Nasdaq: MRX) for potential securities fraud. Investors should contact the firm to learn more.